Researchers at Yale School of Medicine have determined that a panel of biomarkers can help physicians better understand ...

A biomarker panel can improve prediction of chronic kidney disease progression in children aged 6 months to 16 years.

Yale School of Medicine researchers have identified a biomarker panel that improves the assessment of chronic kidney disease ...

Dr. Soma Mandal, a board-certified internist at Summit Health in New Providence, New Jersey, says that getting a CBC test is ...

QUEZON CITY, (PIA) — The National Kidney and Transplant Institute (NKTI) conducted free health screenings for government ...

She is among many patients now asking why, with no apparent change in their blood test results, chronic kidney disease (CKD) is suddenly appearing as a problem on their medical charts. The answer is ...

Jimmy "MrBeast" Donaldson and his creative team join the show's winner Jeffrey Randall Allen for a discussion about the big-money competition series.

An FDA advisory committee has narrowly voted in favour of approval of Mallinckrodt’s terlipressin for hepatorenal syndrome type 1 (HRS-1), after the agency questioned the findings of a phase 3 ...

Discover how GLP-1 drugs are driving demand for new supplements. Insights from Vitafoods Europe 2025 reveal how the industry ...

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce the successful de ...

The FDA approved mitomycin intravesical solution (Zusduri) as a nonsurgical option for recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC). The product won the indication ...